OTraces Awarded $2 Million Florida Grant to Advance Non‑Invasive, High‑Accuracy Prostate Cancer Detection
State-funded clinical study will validate the OTraces’ proteomic blood test ability to reduce unnecessary prostate biopsies in men with elevated PSA DEERFIELD BEACH, Fla. — OTraces, Inc., a diagnostics company…